McAlevey Michael R 4

What Happened Michael R. McAlevey, Executive Vice President and Chief Legal & Administrative Officer of HCA Healthcare (HCA), received a grant of 8,067 stock appreciation rights (SARs) on January 29, 2026. The SARs were reported at $0.00 per share (award/derivative), meaning this was a non-cash equity award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-01-29; Filing date: 2026-02-02 (filed within the two-business-day window, timely).
• Award: 8,067 SARs granted; reported price $0.00 (code A, award/derivative).
• Shares owned after the transaction: not specified in the provided filing.
• Footnote: The SARs vest in four equal annual installments beginning January 29, 2027.
• Filing accession: 0001193125-26-034008.

Context

• Stock appreciation rights are a derivative award that typically pays the holder the increase in share value (in stock or cash) upon vesting or exercise; they do not represent immediate ownership of common stock.
• Grants like this are common as part of executive compensation and do not by themselves signal a buy or sell of company stock.